Characterization of the novel allele, HLA‐B*40:509Q in a Chinese individual
HLA · 2024
DOI: 10.1111/tan.15268 ↗Kurz gefasst
Fachartikel in der Zeitschrift HLA, 2024. Verfasst von Nanying Chen und 4 weiteren Autor:innen. Beteiligte Einrichtung: HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China. Hauptthemen laut MEDLINE: Genes, MHC Class I, HLA-B Antigens, East Asian People. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Science Research Foundation of Zhejiang Healthy Bureau.
Abstract (Originalsprache)
HLA‐B*40:509Q differs from HLA‐B*40:01:02:01 by a three nucleotide deletion at position 764 to 766 in exon 4.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HLA Typing Laboratory, Blood Center of Zhejiang Province, Hangzhou, China.
- HLA Typing Laboratory, Key Laboratory of Blood Safety Research of Zhejiang Province, Hangzhou, China.
ORCID-Profile: Faming Zhu
Förderung
- Science Research Foundation of Zhejiang Healthy Bureau
Zitieren
APA
Chen, N., Zhao, S., Zhang, W., He, J., & Zhu, F. (2024). Characterization of the novel allele, HLA‐B*40:509Q in a Chinese individual. HLA. https://doi.org/10.1111/tan.15268
Vancouver
Chen N, Zhao S, Zhang W, He J, Zhu F. Characterization of the novel allele, HLA‐B*40:509Q in a Chinese individual. HLA. 2024. doi:10.1111/tan.15268
BibTeX
@article{Chen2024,
author = {Chen, Nanying and Zhao, Shuoxian and Zhang, Wei and He, Ji and Zhu, Faming},
title = {Characterization of the novel allele, HLA‐B*40:509Q in a Chinese individual},
journal = {HLA},
year = {2024},
doi = {10.1111/tan.15268}
}
EUVIMED